‘We Lost Our Community, We Lost Our Neighborhood’: What We Heard This Week
"Not only did we lose our home. We lost our community, we lost our neighborhood." -- Sion Roy, MD, of ...
"Not only did we lose our home. We lost our community, we lost our neighborhood." -- Sion Roy, MD, of ...
Amid inflation and an exodus of healthcare personnel, practices reduce services, ultimately leading to decreased quality. This is called "skimpflation," ...
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine ...
McNally is a gynecologic oncologist and surgeon. With today's medical advancements and technologies, innovation in the surgical field is creating ...
Postmenopausal hormone therapy (HT) did not significantly increase the risk of glioma, leaving unresolved the reason for the sex disparity ...
Share on PinterestRecent reports on moderate alcohol consumption have left many people wondering whether it’s safe to drink at all. ...
Cerebrospinal fluid analysis revealed elevated neurofilament light protein and proenkephalin levels 23 years before clinical diagnosis of Huntington's disease.Brain imaging ...
Less than half of patients who were positive for high-risk human papillomavirus (HPV) with negative cytologic findings were retested during ...
Physicians would get a 3% Medicare fee-for-service pay increase -- with primary care doctors getting a little more and other ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or ...
The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received ...
A grand jury in Massachusetts has indicted a rheumatologist who is accused of sexually assaulting more than 200 former patients ...
Many online sellers of compounded GLP-1 receptor agonists may be misleading customers, a cross-sectional study suggested. Out of 79 websites ...
More debate about whether the lowest-risk prostate cancers should even be called "cancer." (Harvard Health Publishing) Four cancer drugs -- ...
Findings from the phase III PATINA trial, presented at the San Antonio Breast Cancer Symposium, showed that adding the CDK4/6 ...
Landry and Lewiss are emergency medicine physicians. Academic scholars -- clinicians, researchers, and administrators who work at academic institutions and ...
The Texas judge who previously halted approval of the nation's most common method of abortion ruled Thursday that three states ...
(Reuters) - Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often ...
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index (BMI) ...
© 2022 NewsHealth.
© 2022 NewsHealth.